Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Inflammation of the glomeruli status post infection with nephritogenic streptococci, most often group A beta hemolytic streptococcus.
Biomarker and diagnostic research for acute proliferative glomerulonephritis has been reported in the published literature.
No clinical trials have been registered for acute proliferative glomerulonephritis.
90 publications have been identified in PubMed for acute proliferative glomerulonephritis. Research spans Case Report / Case Series (58%), Epidemiology / Natural History (21%), and Review / Meta-Analysis (12%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 52 | 58% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 6:44 AM UTC
Common questions about acute proliferative glomerulonephritis
Disease patterns and progression
19 |
21% |
Research summaries | 11 | 12% |
Other research | 3 | 3% |
Clinical study results | 2 | 2% |
Laboratory research | 2 | 2% |
Testing and diagnosis research | 1 | 1% |
Saunders A (2026). [PMID: 41436180](https://pubmed.ncbi.nlm.nih.gov/41436180/). *Arch Dis Child*. [Other]
Vakiti A (2026). [PMID: 29763127](https://pubmed.ncbi.nlm.nih.gov/29763127/). *Unknown Journal*. [Case Report / Case Series]
Larrazábal A (2026). [PMID: 42125421](https://pubmed.ncbi.nlm.nih.gov/42125421/). *Case Rep Hematol*. [Case Report / Case Series]
Loh J (2026). [PMID: 41310998](https://pubmed.ncbi.nlm.nih.gov/41310998/). *J Paediatr Child Health*. [Case Report / Case Series]
Tolentino Júnior DS (2026). [PMID: 41945225](https://pubmed.ncbi.nlm.nih.gov/41945225/). *CEN Case Rep*. [Epidemiology / Natural History]
Shah T (2026). [PMID: 41988540](https://pubmed.ncbi.nlm.nih.gov/41988540/). *Eur J Case Rep Intern Med*. [Case Report / Case Series]
Sugiura T (2026). [PMID: 41893989](https://pubmed.ncbi.nlm.nih.gov/41893989/). *CEN Case Rep*. [Clinical Trial Publication]
Maekawa S (2026). [PMID: 41999621](https://pubmed.ncbi.nlm.nih.gov/41999621/). *Nephron*. [Case Report / Case Series]
Visch R (2026). [PMID: 42232824](https://pubmed.ncbi.nlm.nih.gov/42232824/). *Kidney Med*. [Case Report / Case Series]
James V (2026). [PMID: 41878457](https://pubmed.ncbi.nlm.nih.gov/41878457/). *Front Pediatr*. [Case Report / Case Series]
AI-curated news mentioning acute proliferative glomerulonephritis
Updated Aug 20, 2026
A recent study identifies key factors influencing disease severity in adults with acute glomerulonephritis. This descriptive retrospective cohort study provides insights that could inform future clinical management strategies.
A rare case study highlights late presentation of de novo proliferative glomerulonephritis with monoclonal IgG deposits in a renal allograft. This unusual clinical course provides insights into the complexities of renal transplant complications.
A study reveals inconsistencies between serum IgG κ and glomerular IgA λ chain types in patients with proliferative glomerulonephritis with monoclonal deposits. The research highlights the successful treatment of this condition using daratumumab-based therapy.